Dissertation > Excellent graduate degree dissertation topics show

The Research Progression of Portal Hypertension Treat by Conbined Treatment of Traditional Chinese Medicine and Western Meditreatment

Author: YangLiPing
Tutor: MaJian
School: Heilongjiang University of Traditional Chinese Medicine
Course: Chinese medicine
Keywords: Hepatocirrhosis The pathophysiology of portal hypertension Traditional Chinese drug
CLC: R575.2
Type: Master's thesis
Year: 2008
Downloads: 61
Quote: 0
Read: Download Dissertation


Hepatocirrhosis is world disease,and it is frequently encountered disease in China,too.There are different about cirrhosis cause all over the world,in China,cirrhosis cause mainly are virus hepatitides(hepatitis)、schistosomiasis、alcoholism,etc.Causes of kinds of cirrhosis all may induce inflammation necrosis.Hepatic cell inflammation、necrosis must relate to fiberr egeneration,then to fibrosis.dMain cells of cirrhosis is hepatic star cell(HSC) in last years.The effect of HSC on portal hypertensive has been more thought.After HSC activation;smooth muscle actin in cells more express,which increase contractility of HSC.High or low of portal vein is related to its inhibition and flow.Contractition of HSC reguladtes portal vein inhibition and flow.For many years it has been accepted that hepatic stellate cells(HSCs) play a key role in hepatic fibrosis.Accumulating evidence from in vitro and in vivo studies suggests that stellate cells are also involved in the regulation of the liver microcirculation and portal hypertension.Activated hepatic stellate cells contract or relax in response to a number of vasoactive substances,such as endothelin 1(ET-1)、angiotensin(AngⅡ)et al. Because HSCs play a role in both fibrosis and portal hypertension,they are currently regarded as therapeutic targets to prevent and treat liver disease. Compound Radixglycyrrhizae and Radix Salviae Miltiorrhizae(GLYSAL) is a widely used Chinese herb in anti-fibrosis therapy,several prescriptions have been considered as an effective antifiberosis drugs.

Related Dissertations

  1. A Review and Retrospective Study of Hepatocirrhosis: Disease Reason, Mechanism, Diagnosis and Treatment,R575.2
  2. The Detection of Hemodynamics in the Portal Vien and the Splenic Vein in Patients with Liver Cirrhosis by Color Doppler Flow Imaging Clinically,R575.2
  3. Differential Expression of aphA and HSP70 of E.coli Isolates from Ducks and the Elimination of Drug Resistance of E.coli by Traditional Chinese Drug,S852.61
  4. The Ultrasound Diagnosis of Cirrhotic Portal Hypertension and Hemodynamic Change,R445.1
  5. Clinical Significance of Ghrelin and Inflammatory Cytokines Detected in the Peripheral Blood of Patients with Chronic Hepatic Disease,R446.6
  6. Effect of Baoshen Recipe on the Renal Pathological Changes in Diabetic Rats,R285.5
  7. Clinical Research of Types of Syndrome of TCM of Hepatitis Hepatocirrhosis and Treatment Studies of the Ruan Gan Xiao Ji Tang,R259
  8. Chinese medicine clinical trial quality control and assurance,R28
  9. Data Management System Design and Applied Research in Clinical Trials of Newly-developed Drug of Chinese Materia Medica,R28
  10. The Research of Risk and Benefit Assessment on Clinical Trials of Newly-developed Drug of Chinese Material Medica,R285
  11. The Research of Curative Effect and Mechanism on Anti-Hepatic Fibrosis Interfered by RouganyixianYin,R285
  12. Value of Serum Cholinesterase Activity (CHE) to Evaluate Liver Reserve Function in Cirrhotic Patients in Operation,R657.3
  13. The History and Cultural Analysis of the Processing of TCM,R283
  14. Analysis of the 88 Patients with Primary Liver Cancer,R735.7
  15. Circulating Levels and Clinical Significance of Soluble CD40 in Patients with Liver Disease,R392
  16. Studies on the Therapy of End-stage Liver Disease by Bone Marrow Stem Cells Transplantation,R657.3
  17. Clinical observation of patients with advanced cirrhosis positive Huayu recipe,R259
  18. Clinic Study of the Dangerous Factors for the Hepatocirrhosis Ascites with Spontaneous Bacillary Peritonitis,R575.2
  19. Study of Proclinical Pharmacy on Rehmanni a Glutinosa Oligosaccharides Capsule(The Class V of New Chinese Drug),R285
  20. Chinese Herbal Medicine effective material and basic research methodology design and its application,R284

CLC: > Medicine, health > Internal Medicine > Digestive and abdominal diseases > Liver and gall bladder disease > Cirrhosis
© 2012 www.DissertationTopic.Net  Mobile